Innate Pharma absorbs profit-taking and gains 50 percent
Innate Pharma stock recorded a 50 percent gain in the trading session, representing approximately 5 million shares traded.
Published 12sem1 sourceMajorupdated 3j
Lire en français
≈ 22s
The fact
This increase reflects either a speculative rebound or a market already recognizing the company's prospects.
The American market at opening could amplify this bullish dynamic observed during trading.
Click the link to read an article on the topic: